Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Cytovation ASA
ASA
Active
Org 983644600
Solheimsgaten 11, 5058
Bergen
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2001 · 24 years old
3 employees
Monitor
Share
Norway
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Cytovation ASA
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
0M
0M
0M
-1M
-1M
2020: 0M
0M
2020
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
EBITDA
NOK millions
0M
-38M
-76M
-114M
-152M
2020: -37M
-37M
2020
2021: -34M (+8% vs 2020)
-34M
+8%
2021
2022: -122M (-259% vs 2021)
-122M
-259%
2022
2023: -77M (+37% vs 2022)
-77M
+37%
2023
2024: -55M (+29% vs 2023)
-55M
+29%
2024
Income statement
NOK thousands
Item
2024
2023
2022
2021
2020
Revenue
0
0
0
0
0
Staff expenses
−6 631
−6 672
−2 697
−0
−0
EBITDA
−54 808
−77 245
−122 064
−33 706
−36 937
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
−54 808
−77 245
−122 064
−33 706
−36 937
Net financials
−8 087
−4 267
−845
−660
−761
Profit before tax
−62 895
−81 512
−122 909
−34 365
−37 699
Tax
−0
−0
−0
−0
−0
Net profit
−62 895
−81 512
−122 909
−34 365
−37 699
Balance sheet
NOK thousands
Item
2024
2023
2022
2021
2020
Total assets
15 779
78 156
83 918
107 452
5 806
Equity
−93 332
−30 437
51 075
87 110
−10 013
Long-term debt
100 239
91 126
10 906
10 906
0
Short-term debt
8 872
17 467
21 936
9 436
15 819
Total debt
109 111
108 593
32 842
20 342
15 819
Financial ratios
5-year trend
EBITDA margin
<−999 %
This company
15,8 %
Market median
This company
Market median
>999% below market
2020
2024
Equity ratio
−591,5 %
This company
38,2 %
Market median
This company
Market median
>999% below market
2020
2024
Return on equity
—
This company
18,4 %
Market median
This company
Market median
2020
2024
Net profit margin
<−999 %
This company
8,1 %
Market median
This company
Market median
>999% below market
2020
2024
Asset turnover
0,00×
This company
1,12×
Market median
This company
Market median
100% below market
2020
2024
Debt / equity
—
This company
0,62×
Market median
This company
Market median
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
More on Cytovation ASA
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
